- Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma
-
Krajewska , Jarzab M, Kukulska A, Czarniecka A, Roskosz J, Puch Z, Wygoda Z, Paliczka-Cieslik E, Kropinska , Krol A, Handkiewicz-Junak D, Jarzab B
- KMID: 2465867
- Nucl Med Mol Imaging.
- 2019 Oct;53(5):320-327.
- doi: 10.1007/s13139-019-00608-8
PURPOSE: Although postoperative radioiodine (RAI) therapy has been used in patients with differentiated thyroid carcinoma (DTC) for many years, there is still lack of data defining the timing of RAI... -
- CITED
-
- Close
- SHARE
-
- Close
